Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Sundry Debtors

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Sundry Debtors ₹576 Cr₹388 Cr₹331 Cr₹531 Cr₹220 Cr

What is the latest Sundry Debtors ratio of MANKIND PHARMA ?

The latest Sundry Debtors ratio of MANKIND PHARMA is ₹576 Cr based on Mar2023 Consolidated results.
Year Sundry Debtors
Mar2023₹576 Cr
Mar2022₹388 Cr
Mar2021₹331 Cr
Mar2020₹531 Cr
Mar2019₹220 Cr

How is Sundry Debtors of MANKIND PHARMA Trending?

Years Sundry Debtors % Change
Mar2023 ₹576 Cr
48.50
Mar2022 ₹388 Cr
17.41
Mar2021 ₹331 Cr
-37.75
Mar2020 ₹531 Cr
141.17
Mar2019 ₹220 Cr -

Compare Sundry Debtors of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -4% -8.3% 51.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 0.4% -0.4% 61.2% Stock Analytics
CIPLA ₹112,990.0 Cr -1.1% 1.7% 53.9% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 5.9% 11.3% 94.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr -0.1% 3.9% 20% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -2% -4.2% 29.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4%

-8.3%

51.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses